Literature DB >> 16703290

A dosimetric comparison of IORT techniques in limited-stage breast cancer.

Olaf Nairz1, Heinz Deutschmann, Michael Kopp, Karl Wurstbauer, Gerhard Kametriser, Gerd Fastner, Florian Merz, Roland Reitsamer, Christian Menzel, Felix Sedlmayer.   

Abstract

BACKGROUND AND
PURPOSE: For intraoperative radiotherapy (IORT) during breast-conserving treatment four different techniques have been addressed: interstitial brachytherapy, an inflatable balloon with a central high-dose-rate source (MammoSite), a miniature orthovolt system (Intrabeam), and linac-based electron radiotherapy (IOERT). The dosimetric properties of these methods are compared.
MATERIAL AND METHODS: Planning target volumes (PTVs) of the same size but of different shapes are assumed, corresponding to the technique's specific situs. Dose distributions for the PTVs and for surrounding tissues are demonstrated by dose-volume histograms and a list of physical parameters. A dose inhomogeneity index (DII) is introduced to describe the deviation of a delivered from the prescribed dose, reaching its minimal value 0 in case of perfect homogeneity.
RESULTS: In terms of DII, IOERT reaches the lowest value followed by the MammoSite, the Intrabeam and interstitial implants. The surrounding tissues receive the smallest average dose with IOERT, closely followed by the orthovolt system.
CONCLUSION: When comparing simplified geometric figures, IOERT delivers the most homogeneous dose distributions. However, in clinical reality PTVs often present asymmetric shapes instead of ideal geometries. Due to a strictly centric dose fall-off, any system with a round central applicator will have technical limits. During IOERT margin-directed applicator guidance is possible and interstitial brachytherapy allows for polygonal dose shaping. These techniques seem to be superior for asymmetric PTV irradiation.

Entities:  

Mesh:

Year:  2006        PMID: 16703290     DOI: 10.1007/s00066-006-1580-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  12 in total

1.  Intraoperative radiotherapy of the breast - really a valide option or "only" comfortable.

Authors:  Marc D Piroth
Journal:  Gland Surg       Date:  2013-05

2.  Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer : beware of one-stop shops?

Authors:  Marie-Luise Sautter-Bihl; Felix Sedlmayer; Wilfried Budach; Jürgen Dunst; Rita Engenhart-Cabillic; Rainer Fietkau; Petra Feyer; Wulf Haase; Wolfgang Harms; Claus Rödel; Rainer Souchon; Frederik Wenz; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2010-12       Impact factor: 3.621

3.  The influence of different IMRT techniques on the peripheral dose: a comparison between sMLM-IMRT and helical tomotherapy.

Authors:  Tilo Wiezorek; Andrea Schwahofer; Kai Schubert
Journal:  Strahlenther Onkol       Date:  2009-10-06       Impact factor: 3.621

4.  DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer.

Authors:  F Sedlmayer; M-L Sautter-Bihl; W Budach; J Dunst; G Fastner; P Feyer; R Fietkau; W Haase; W Harms; R Souchon; F Wenz; R Sauer
Journal:  Strahlenther Onkol       Date:  2013-10       Impact factor: 3.621

Review 5.  Boost IORT in Breast Cancer: Body of Evidence.

Authors:  Felix Sedlmayer; Roland Reitsamer; Christoph Fussl; Ingrid Ziegler; Franz Zehentmayr; Heinz Deutschmann; Peter Kopp; Gerd Fastner
Journal:  Int J Breast Cancer       Date:  2014-09-02

6.  Attenuation measurements show that the presence of a TachoSil surgical patch will not compromise target irradiation in intra-operative electron radiation therapy or high-dose-rate brachytherapy.

Authors:  Sandra Sarmento; Filipa Costa; Alexandre Pereira; Joana Lencart; Anabela Dias; Luís Cunha; Olga Sousa; José Pedro Silva; Lúcio Santos
Journal:  Radiat Oncol       Date:  2015-01-09       Impact factor: 3.481

Review 7.  Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases-Implications for Intraoperative Radiotherapy after Resection.

Authors:  Carsten Herskind; Frederik Wenz; Frank A Giordano
Journal:  Front Oncol       Date:  2017-07-24       Impact factor: 6.244

Review 8.  Biology of high single doses of IORT: RBE, 5 R's, and other biological aspects.

Authors:  Carsten Herskind; Lin Ma; Qi Liu; Bo Zhang; Frank Schneider; Marlon R Veldwijk; Frederik Wenz
Journal:  Radiat Oncol       Date:  2017-01-19       Impact factor: 3.481

Review 9.  Intraoperative radiotherapy (IORT) as boost in breast cancer.

Authors:  Felix Sedlmayer; Roland Reitsamer; Frederik Wenz; Elena Sperk; Christoph Fussl; Julia Kaiser; Ingrid Ziegler; Franz Zehentmayr; Heinz Deutschmann; Peter Kopp; Gerd Fastner
Journal:  Radiat Oncol       Date:  2017-01-19       Impact factor: 3.481

10.  Early invasive cancer and partial intraoperative electron radiation therapy of the breast: experience of the jules bordet institute.

Authors:  C Philippson; S Simon; C Vandekerkhove; D Hertens; I Veys; D Noterman; F De Neubourg; D Larsimont; P Bourgeois; P Van Houtte; J M Nogaret
Journal:  Int J Breast Cancer       Date:  2014-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.